Novelix Pharmaceuticals Ltd (536565) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 536565 | NSE: | Trading | Small Cap

Novelix Pharma Share Price

59.78 2.11 3.66%
as on 26-Dec'25 16:59

DeciZen - make an informed investing decision on Novelix Pharma

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Novelix Pharmaceuticals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
106.09
Market Cap:
102.9 Cr.
52-wk low:
24.2
52-wk high:
70.2

Is Novelix Pharmaceuticals Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Novelix Pharma: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Novelix Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 1.2%1.8%2.5%1.6%0.9%-31.3%-19.5%-0.8%0.3%1%-
Value Creation
Index
-0.9-0.9-0.8-0.9-0.9-3.2-2.4-1.1-1.0-0.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.93.53.13.6110.81.44.230.785
Sales YoY Gr.-277.4%-11.4%15.4%-71.3%-1.9%-16.8%66.7%201.4%628%-
Adj EPS 0.10.10.30.20.1-4-0.6-0.3-0.10.10.6
YoY Gr.--22.2%271.4%-23.1%-60%-5137.5%NANANANA-
BVPS (₹) 14.114.314.614.814.910.98.98.99.117.618.1
Adj Net
Profit
0.10.10.20.20.1-3.3-0.5-0.2-0.10.11
Cash Flow from Ops. 2-1.11.1-0.41.20.60.6-2.4-0.3-13.7-
Debt/CF from Ops. 0000000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 47.5%97.2%231.9%628%
Adj EPS 0%2.4%NANA
BVPS2.5%3.4%25.4%94.2%
Share Price 23.4% 57.3% 81.5% 147.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
0.60.51.81.30.5-31.3-6.2-3.2-0.70.83.1
Op. Profit
Mgn %
42.75.215.35-27.6-346.8-62-36.9-5.40.51.5
Net Profit
Mgn %
7.51.76.84.46.3-324.1-58.9-16.4-1.20.31.1
Debt to
Equity
00000000000
Working Cap
Days
3,3018591,0338902,8511,8881,12377934518073
Cash Conv.
Cycle
25328515340787207209946234

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Novelix Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 0.6 -0.9
TTM Sales (₹ Cr.) 84.9 1.2
BVPS (₹.) 18.1 0
Reserves (₹ Cr.) 14 2
P/BV 3.31 0.00
PE 106.09 0.00
From the Market
52 Week Low / High (₹) 24.15 / 70.16
All Time Low / High (₹) 1.85 / 74.60
Market Cap (₹ Cr.) 103
Equity (₹ Cr.) 17.2
Face Value (₹) 10
Industry PE 35.3

Management X-Ray of Novelix Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Novelix Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Novelix Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales14341111431
Operating Expenses 13331532431
Manufacturing Costs0000000000
Material Costs03231111430
Employee Cost 0000000000
Other Costs 0000032001
Operating Profit 0000-0-4-2-1-00
Operating Profit Margin (%) 42.6%5.2%13.9%5.0%-27.9%-348.0%-242.0%-36.9%-5.8%0.5%
Other Income 0000001100
Interest 0000000000
Depreciation 0000000000
Exceptional Items 0000000000
Profit Before Tax 00000-3-2-000
Tax 000-00-0-0000
Profit After Tax 00000-3-2-000
PAT Margin (%) 10.6%4.3%5.8%7.0%9.2%-324.0%-185.0%-4.3%0.2%0.3%
Adjusted EPS (₹)0.10.20.20.30.1-4.0-1.9-0.10.00.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 1112121212977718
Share Capital 88888888810
Reserves 334441-1-1-18
Minority Interest0000000000
Debt0000000000
Long Term Debt0000000000
Short Term Debt0000000000
Trade Payables0000000009
Others Liabilities 0000-0-0-0-0-00
Total Liabilities 1212121212977727

Fixed Assets

Gross Block3444441112
Accumulated Depreciation3333331111
Net Fixed Assets 1110000000
CWIP 0000000000
Investments 3233441330
Inventories0000001111
Trade Receivables00120000018
Cash Equivalents 0000123001
Others Assets 8877733337
Total Assets 1212121212977727

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 2-11-0111-2-0-14
PBT 00000-3-2-000
Adjustment 000-0-0-01-0-00
Changes in Working Capital 2-11-1241-2-0-14
Tax Paid 0000000000
Cash Flow From Investing Activity -21-10-000003
Capex -0-0-00-0-0-2-00-0
Net Investments -21-10-1022-03
Others -0000001-200
Cash Flow From Financing Activity 00000000011
Net Proceeds from Shares 0000000003
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0000000008
Net Cash Flow 0-0-00111-2-01

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)0.861.311.552.10.79-31.32-19.45-0.830.140.68
ROCE (%)1.21.782.51.60.89-31.33-19.51-0.810.311
Asset Turnover Ratio0.080.30.260.290.090.10.110.20.581.78
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days2521881653923040389108
Inventory Days023191132591691768712
Payable Days002727274015357

Novelix Pharmaceuticals Ltd Stock News

Novelix Pharmaceuticals Ltd FAQs

The current trading price of Novelix Pharma on 26-Dec-2025 16:59 is ₹59.78.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 25-Dec-2025 the market cap of Novelix Pharma stood at ₹102.9.
The latest P/E ratio of Novelix Pharma as of 25-Dec-2025 is 106.1.
The latest P/B ratio of Novelix Pharma as of 25-Dec-2025 is 3.31.
The 52-week high of Novelix Pharma is ₹70.16 and the 52-week low is ₹24.15.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Novelix Pharma is ₹84.87 ( Cr.) .

About Novelix Pharmaceuticals Ltd

Trimurthi Drugs & Pharmaceuticals is an India-based company. The Company is engaged in the manufacturing, distribution, marketing and trading of pharmaceutical products. The Company’s range of products include antibiotics, anti ulcer, anti inflammatory, antitussive/expectorant, cardiovascular, anti fungal, anti retroviral drugs, syrups and protein powder. The company since 1976 is built on the philosophy of commitment to quality and responsiveness.

2012 -The Company entered into a Manufacturing Agreement with M/s. Bharat Parenterals Limited, Vadodara, Gujrat for exclusive manufacture of Company's 12 products for export. The Company entered into Distribution Agreement with Zyanya Global Pte Limited, Vietnam for selling the Company's Products in Vietnam.

Business areas of the company:

The company is engaged in the manufacturing, distribution, marketing and trading of pharmaceutical products.

Divisions:

Pharma Business, Financial Services, Investment in Shares and Trading in Shares

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×